ASHLEY MILCAREK: Open Payments
NPI 1427736925 · MICHIGAN CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 21 payments from 10 companies in 2025. Trend: 2023 $151 · 2024 $136 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $106 |
| Exeltis, USA Inc. | 3 | $61 |
| Astellas Pharma US Inc | 3 | $54 |
| Biogen, Inc. | 2 | $47 |
| Ethicon US, LLC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Organon LLC | 1 | $6 |
Products named: VRAYLAR, SLYND, Veozah, ZURZUVAE, SURGICEL NU-KNIT, Mirena, Cologuard Collection Kit, JOURNAVX.
Industry payments across IN — which companies pay providers there.
